Dexamethasone Induces Rapid Serine-Phosphorylation and Membrane Translocation of Annexin 1 in a Human Folliculostellate Cell Line via a Novel Nongenomic Mechanism Involving the Glucocorticoid Receptor, Protein Kinase C, Phosphatidylinositol 3-Kinase, and Mitogen-Activated Protein Kinase
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Our recent studies on rat pituitary tissue suggest that the annexin 1 (ANXA1)-dependent inhibitory actions of glucocorticoids on ACTH secretion are effected via a paracrine mechanism that involves protein kinase C (PKC)-dependent translocation of a serine-phosphorylated species of ANXA1 (Ser-P-ANXA1) to the plasma membrane of the nonsecretory folliculostellate cells. In the present study, we have used a human folliculostellate cell line (PDFS) to explore the signaling mechanisms that cause the translocation of Ser-P-ANXA1 to the membrane together with Western blot analysis and flow cytometry to detect the phosphorylated protein. Exposure of PDFS cells to dexamethasone caused time-dependent increases in the expression of ANXA1 mRNA and protein, which were first detected within 2 h of steroid contact. This genomic response was preceded by the appearance within 30 min of substantially increased amounts of Ser-P-ANXA1 and by translocation of the phosphorylated protein to the cell surface. The prompt membrane translocation of Ser-P-ANXA1 provoked by dexamethasone was inhibited by the glucocorticoid receptor, antagonist, mifepristone, but not by actinomycin D or cycloheximide, which effectively inhibit mRNA and protein synthesis respectively in our preparation. It was also inhibited by a nonselective PKC inhibitor (PKC9–31), by a selective inhibitor of Ca2+-dependent PKCs (Go 6976) and by annexin 5 (which sequesters PKC in other systems). In addition, blockade of phosphatidylinositiol 3-kinase (wortmannin) or MAPK pathways with PD 98059 or UO 126 (selective for MAPK kinse 1 and 2) prevented the steroid-induced translocation of Ser-P-ANXA1 to the cell surface. These results suggest that glucocorticoids induce rapid serine phosphorylation and membrane translocation of ANXA1 via a novel nongenomic, glucocorticoid receptor-dependent mechanism that requires MAPK, phosphatidylinositiol 3-kinase, and Ca2+-dependent PKC pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of glucocorticoids to GR not only activates the receptor, but also liberates accessory proteins that participate in secondary signaling cascades.”
From Corticosteroids (2016) · cites this paper as [39]
In the citing paper
“For example, when released from the inactive GR protein complex, c-Src activates signaling cascades that inhibit phospholipase A2 activity, phosphorylate annexin 1, and impair the release of arachidonic acid38, 39.”
From Corticosteroids (2016) · cites this paper as [39]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Raynal, P., & Pollard, H. B. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(94)90019-1 · Cited by 1,099
Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate.
Nakanishi, H., Brewer, K. A., & Exton, J. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54107-7 · Cited by 965
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959
FLOWER, R. J., & BLACKWELL, G. J. (1979) · Nature · doi:10.1038/278456a0 · Cited by 917
Self-citationWallner, B. P., Mattaliano, R. J., Hession, C., Cate, R. L., Tizard, R., Sinclair, L. K., Foeller, C., Chow, E. P., Browning, J. L., Ramachandran, K. L., et al. (1986) · Nature · doi:10.1038/320077a0 · Cited by 664
Toker, A., Meyer, M., Reddy, K. K., Falck, J. R., Aneja, R., Aneja, S., Parra, A., Burns, D. J., Ballas, L. M., & Cantley, L. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31643-0 · Cited by 553
Neurosteroids: Beginning of the story
Baulieu, E. E., Robel, P., & Schumacher, M. (2001) · International Review of Neurobiology · doi:10.1016/s0074-7742(01)46057-0 · Cited by 352
Croxtall, J. D., Choudhury, Q., & Flower, R. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703272 · Cited by 332
Self-citationGlucocorticoid Receptor-Like Antigen in Lymphoma Cell Membranes: Correlation to Cell Lysis
Gametchu, B. (1987) · Science · doi:10.1126/science.3563523 · Cited by 183
Research works printed but not linked: 1
- Mulla, 2000, Expression of Annexin 1 (lipocortin 1) and Annexin 5 in human pituitary tumors, J Endocr, 167
Cited by
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
“…increase AnxA1 expression on human monocytes and neutrophils in vivo (Goulding et al., 1990) and in pituitary folliculostellate cells in vitro (Solito et al., 2003) and whilst the underlying mechanisms remain unclear, they appear to involve both non-genomic and genomic actions of…”
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“When liberated from the GR complex, c-Src activates multiple kinase cascades that lead to the phosphorylation of annexin 1, inhibition of cytosolic phospholipase A2 activity, and impaired release of arachidonic acid (46, 47).”
BackgroundRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Extranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475
“Treatment of human pituitary folliculostellate cells with glucocorticoid leads to rapid phosphorylation of annexin-1, followed by its translocation to the cell membrane where it contributes to the inhibition of ACTH secretion (162).”
BackgroundRapid non-genomic effects of corticosteroids and their role in the central stress response
Groeneweg, F. L., Karst, H., de Kloet, E. R., & Joëls, M. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0472 · Cited by 414
“Thus, a rapid and non-genomic translocation of annexin-I by dexamethasone was prevented by GR-antagonist treatment in a pituitary-derived cell line (Solito et al. 2003).”
BackgroundAnnexin 1: the new face of an old molecule
Lim, L. H. K., & Pervaiz, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7464rev · Cited by 399
Groeneweg, F. L., Karst, H., de Kloet, E. R., & Joëls, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.020 · Cited by 289
Anti-inflammatory functions of glucocorticoid-induced genes
Clark, A. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.013 · Cited by 274
“Although AnxA1 mRNA expression is upregulated by GCs this response tends to be quite slow and modest (less than two-fold) (Solito et al., 2003).”
Backgroundvan Genderen, H. O., Kenis, H., Hofstra, L., Narula, J., & Reutelingsperger, C. P. M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.030 · Cited by 230
Bartholome, B., Spies, C. M., Gaber, T., Schuchmann, S., Berki, T., Kunkel, D., Bienert, M., Radbruch, A., Burmester, G., Lauster, R., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0328com · Cited by 229
New dimension of glucocorticoids in cancer treatment
Lin, K.-T., & Wang, L.-H. (2016) · Steroids · doi:10.1016/j.steroids.2016.02.019 · Cited by 204
“GR has been shown to interact with and alter the activity of several kinases, including JNK [8], Src [9], ERK1/2 [10,11], phosphatidylinositol 3-kinae (PI3K) [12], and protein kinase C (PKC) [13].”
Haller, J., Mikics, É., & Makara, G. B. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.004 · Cited by 203
Löwenberg, M., Stahn, C., Hommes, D. W., & Buttgereit, F. (2008) · Steroids · doi:10.1016/j.steroids.2007.12.002 · Cited by 201
Annexin A1: Uncovering the Many Talents of an Old Protein
Sheikh, M., & Solito, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041045 · Cited by 195
“Serine-27 phosphorylation along with lipidation [30] induces ANXA1 translocation onto the membrane via MAPK, PI3K and PKC-dependent signalling cascades [31].”
BackgroundSelf-citationAnnexin‐A1: a pivotal regulator of the innate and adaptive immune systems
D'Acquisto, F., Perretti, M., & Flower, R. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.252 · Cited by 193
Self-citationMaggioli, E., McArthur, S., Mauro, C., Kieswich, J., Kusters, D. H. M., Reutelingsperger, C. P. M., Yaqoob, M., & Solito, E. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.08.020 · Cited by 181
“Phosphorylation of ANXA1 is critically required for its extracellular export and consequent actions (22), and, whilst identification of the kinase(s) responsible lies beyond the scope of this study, suspicion falls upon members of the PKC family, as these enzymes are both activated following GPR30 stimulation (39) and…”
BackgroundSelf-citationBreen, K. M., & Karsch, F. J. (2004) · Endocrinology · doi:10.1210/en.2003-1114 · Cited by 170
“In accord with this thinking, recent evidence in a pituitary cell line suggests glucocorticoids activate the MAPK pathway via a nongenomic mechanism involving GR (32).”
Thomas, P. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2011.11.032 · Cited by 164
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression
Löwenberg, M., Verhaar, A. P., van den Brink, G. R., & Hommes, D. W. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.02.001 · Cited by 189
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
Dugel, P. U., Bandello, F. M., & Loewenstein, A. (2015) · Clinical ophthalmology · doi:10.2147/opth.s79948 · Cited by 159
“35,36 In addition to these nuclear events, the steroid–receptor complex can trigger signal transduction events within the cytosol, 35 such as the release of annexin-1, 37 a modulator of leukocyte trafficking.”
The annexins: spatial and temporal coordination of signaling events during cellular stress
Monastyrskaya, K., Babiychuk, E. B., & Draeger, A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0027-1 · Cited by 142
“Among other functions, annexin A1 is believed to act as a mediator of anti-inflammatory glucocorticoids [92].”
BackgroundChecks and balances: The glucocorticoid receptor and NFĸB in good times and bad
Bekhbat, M., Rowson, S. A., & Neigh, G. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.001 · Cited by 131
New insights regarding glucocorticoids, stress and gonadotropin suppression
BREEN, K., & KARSCH, F. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.03.335 · Cited by 131
Girol, A. P., Mimura, K. K. O., Drewes, C. C., Bolonheis, S. M., Solito, E., Farsky, S. H. P., Gil, C. D., & Oliani, S. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202030 · Cited by 136
“), anti–AnxA1S(27)-PO4 (20, 22, 30), anti–AnxA1-Y (21)-PO4 (1:1000) (30), anti-fpr2 (1:2000) (24, 26), and anti–COX-2 (1:1000) (Invitrogen, Paisley, U.”
BackgroundSelf-citationSolito, E., Christian, H., Festa, M., Mulla, A., Tierney, T., Flower, R. J., & Buckingham, J. C. (2006) · The FASEB Journal · doi:10.1096/fj.05-5319fje · Cited by 126
“They also support the premise that both PI3-kinase and MAPkinase are critical to this event ( 18 ) as also is PKC (10, 18).”
BackgroundMethodResultInfluentialSelf-citationAnnexin-A1: Therapeutic Potential in Microvascular Disease
Purvis, G. S. D., Solito, E., & Thiemermann, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00938 · Cited by 107
“Glucocorticoid administration to peripheral blood mononuclear (PBMN) cells increased ANXA1 expression in both a temporal and dose-dependent manner (9, 10).”
BackgroundSelf-citationKitchener, P., Di Blasi, F., Borrelli, E., & Piazza, P. V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03267.x · Cited by 105
Pathophysiology of Glucocorticoid Signaling
Vitellius, G., Trabado, S., Bouligand, J., Delemer, B., & Lombès, M. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.001 · Cited by 116
Differential gene expression in ACTH -secreting and non-functioning pituitary tumors
Tateno, T., Izumiyama, H., Doi, M., Yoshimoto, T., Shichiri, M., Inoshita, N., Oyama, K., Yamada, S., & Hirata, Y. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0428 · Cited by 101
“It has been reported that ANXA1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH secretion in the rat anterior pituitary (30, 31 ).”
BackgroundXia, Q., Li, X., Zhou, H., Zheng, L., & Shi, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0686-7 · Cited by 93
“the interaction of S100A11 with importin β in N2a cells transfected with Flag-S100A11 (WT), (1-41), and (42–98) plasmids.”
BackgroundThe complex understanding of Annexin A1 phosphorylation
D’Acunto, C. W., Gbelcová, H., Festa, M., & Ruml, T. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.020 · Cited by 89
Matthews, L., Berry, A., Ohanian, V., Ohanian, J., Garside, H., & Ray, D. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0154 · Cited by 88
“Reported nongenomic effects include activation of phosphatidylinositol 3-kinase (PI3K) (13), MAPKs (14), and c-src (8, 15, 16).”
BackgroundAnnexin 1, Glucocorticoids, and the Neuroendocrine–Immune Interface
BUCKINGHAM, J. C., JOHN, C. D., SOLITO, E., TIERNEY, T., FLOWER, R. J., CHRISTIAN, H., & MORRIS, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.002 · Cited by 87
Self-citationMechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
Quattrocelli, M., Zelikovich, A. S., Salamone, I. M., Fischer, J. A., & McNally, E. M. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200556 · Cited by 96
Deng, Q., Riquelme, D., Trinh, L., Low, M. J., Tomić, M., Stojilkovic, S., & Aguilera, G. (2015) · Endocrinology · doi:10.1210/en.2015-1265 · Cited by 77
Fan, H., Huo, L., Chen, D., Schatten, H., & Sun, Q. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.024737 · Cited by 79
“The cooperation of PKC and MAPK in response to the extracellular stimulation has been reported in many cell types [43, 44], including cultured human follicular cells [45].”
BackgroundFilep, J. G., & Ariel, A. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00181.2020 · Cited by 89
Pin, A.-L., Houle, F., Fournier, P., Guillonneau, M., Paquet, É. R., Simard, M. J., Royal, I., & Huot, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393561 · Cited by 89
“On the other hand, many studies have shown that ANXA1 is phosphorylated on tyrosine residues following the activation of EGF and HGF receptor-tyrosine kinases or on serine residues by protein kinase c (19, 20).”
BackgroundNongenomic actions of adrenal steroids in the central nervous system
Evanson, N. K., Herman, J. P., Sakai, R. R., & Krause, E. G. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02000.x · Cited by 76
Annexin A1: shifting the balance towards resolution and repair
Leoni, G., & Nusrat, A. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0180 · Cited by 84
Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy
Hapgood, J. P., Avenant, C., & Moliki, J. M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.002 · Cited by 83
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript well as numerous pathways involved in neuroendocrine synaptic signalling (Di et al., 2009; Malcher-Lopes et al., 2008; Solito et al., 2003; Teng et al., 2013).”
BackgroundThe restorative role of annexin A1 at the blood–brain barrier
McArthur, S., Loiola, R. A., Maggioli, E., Errede, M., Virgintino, D., & Solito, E. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0043-0 · Cited by 80
Self-citationAnnexin 1 and the regulation of endocrine function
John, C., CHRISTIAN, H., Morris, J. F., Flower, R. J., Solito, E., & Buckingham, J. C. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.02.001 · Cited by 80
Self-citationThe Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
Ilie, M. D., Vasiljevic, A., Raverot, G., & Bertolino, P. (2019) · Cancers · doi:10.3390/cancers11101605 · Cited by 78
“on adrenocorticotropic hormone (ACTH) release by corticotroph cells, thus being implicated in the regulation of the hypothalamo–pituitary–adrenal axis [68].”
BackgroundRapid effects of aldosterone on clonal human vascular smooth muscle cells
Gros, R., Ding, Q., Armstrong, S., O’Neil, C. H., Pickering, J. G., & Feldman, R. D. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00407.2006 · Cited by 68
“Also, PI3-kinase activation seems to be a common mechanism underlying the rapid effects of aldosterone as well as of estrogens and glucocorticoids (32, 33).”
BackgroundEndoplasmic Reticulum Stress and the Related Signaling Networks in Severe Asthma
Kim, S. R., & Lee, Y. C. (2015) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2015.7.2.106 · Cited by 64
“It can also induce the phosphorylation and extracellular release of annexin-1.(12) There is recent evidence for an important role of extracellular annexin-1 as an inflammation-resolving protein, acting on the formyl peptide receptors FPR1 and FPR2.”
BackgroundCheung, L. W. T., Leung, K. W., Wong, C. K. C., Wong, R. N., & Wong, A. S. T. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq300 · Cited by 61
Spurr, L., Nadkarni, S., Pederzoli-Ribeil, M., Goulding, N. J., Perretti, M., & D’Acquisto, F. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.006 · Cited by 65
CAF-Secreted Annexin A1 Induces Prostate Cancer Cells to Gain Stem Cell–like Features
Geary, L., Nash, K. A., Adisetiyo, H., Liang, M., Liao, C., Jeong, J. H., Zandi, E., & Roy‐Burman, P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0469 · Cited by 60
The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1
Lima, K. M., Vago, J. P., de Caux, T. R., Negreiros-Lima, G. L., Sugimoto, M. A., Tavares, L. P., Arribada, R. G., Carmo, A. A. F., Galvão, I., Costa, B. R. C., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.800391 · Cited by 63
“Polyclonal anti-Ser(27)-AnxA1 antibody was generated as described previously (75).”
MethodSelf-citationGlucocorticoid-resistant asthma and novel anti-inflammatory drugs
Keenan, C. R., Salem, S., Fietz, E. R., Gualano, R. C., & Stewart, A. G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.011 · Cited by 65
Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation
Brancaleone, V., Mitidieri, E., Flower, R. J., Cirino, G., & Perretti, M. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217034 · Cited by 64
“One of themechanisms engaged by PMN to release AnxA1 relies on the phosphorylation of AnxA1, and this involves a mechanism based on agonist-receptor interaction (Solito et al., 2003; Yazid et al., 2010).”
BackgroundSelf-citationLuo, Z., Gao, Y., Sun, N., Zhao, Y., Wang, J., Tian, B., & Shi, J. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.013 · Cited by 59
“The stimulation of NMDA receptors by glutamate can evoke a calcium influx that activates the PKC pathway, and annexin-1 can be activated as a consequence of sequential PI3K–PKC activation (John et al., 2002; Solito et al., 2003).”
BackgroundAnnexins — Scaffolds modulating PKC localization and signaling
Hoque, M., Rentero, C., Cairns, R. F., Tebar, F., Enrich, C., & Grewal, T. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.012 · Cited by 65
Breen, K. M., Davis, T. L., Doro, L. C., Nett, T. M., Oakley, A. E., Padmanabhan, V., Rispoli, L. A., Wagenmaker, E. R., & Karsch, F. J. (2008) · Endocrinology · doi:10.1210/en.2007-0773 · Cited by 55
“Furthermore, recent evidence in a human pituitary cell line suggests glucocorticoids activate the MAPK pathway within 30 min, via a nongenomic mechanism involving the type II GR ( 30 ).”
BackgroundCooperativity and complementarity: Synergies in non-classical and classical glucocorticoid signaling
Samarasinghe, R. A., Witchell, S. F., & DeFranco, D. B. (2012) · Cell Cycle · doi:10.4161/cc.21018 · Cited by 54
Glucocorticoid action and the development of selective glucocorticoid receptor ligands
Cole, T. J. (2006) · Biotechnology annual review · doi:10.1016/s1387-2656(06)12008-6 · Cited by 68
Breen, K. M., Stackpole, C. A., Clarke, I. J., Pytiak, A. V., Tilbrook, A. J., Wagenmaker, E. R., Young, E. A., & Karsch, F. J. (2004) · Endocrinology · doi:10.1210/en.2004-0123 · Cited by 53
“Recent evidence in a human pituitary cell line suggests that glucocorticoids activate the MAPK pathway via a nongenomic mechanism involving GR (49).”
BackgroundTalabér, G., Boldizsár, F., Bartis, D., Pàlinkàs, L., Szabó, M., Berta, G., Sétáló, G., Németh, P., & Berki, T. (2009) · International Immunology · doi:10.1093/intimm/dxp093 · Cited by 54
Zhao, Y., Wang, J., Jiang, H., Yu, Z., Li, X., & Shi, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8781-y · Cited by 52
“A number of studies have demonstrated that intracellular localization of annexin 1 can be redistributed following specific stimulation, for example, in response to glucocorticoids [23], lipopolysaccharides [24], and hepatocyte growth factors [25].”
Mulla, A., Christian, H., Solito, E., Mendoza, N., Morris, J. F., & Buckingham, J. C. (2003) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01936.x · Cited by 50
Self-citationMulla, A., LeRoux, C., Solito, E., & Buckingham, J. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1230 · Cited by 50
“In support of this premise, we recently described rapid (within 30 min) positive effects of glucocorticoids on ANXA1 expression in other tissues that are blocked by inhibitors of translation but not transcription and may therefore require translation of preformed mRNA (10, 17).”
BackgroundMethodSelf-citationCôté, M. C., Lavoie, J. R., Houle, F., Poirier, A., Rousseau, S., & Huot, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098665 · Cited by 51
An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance
Ingawale, D. K., Mandlik, S. K., & Patel, S. S. (2014) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2014-0051 · Cited by 52
Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes
Sawmynaden, P., & Perretti, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.179 · Cited by 51
Treating gliomas with glucocorticoids: from bedside to bench
Piette, C., Munaut, C., Foidart, J., & Deprez, M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0100-x · Cited by 56
“In a human folliculo-stellate cell line, dexamethasone has been shown to induce a rapid serine phosphorylation and membrane translocation of ANXA1 via a mechanism that requires MAPK, phosphatidylinositol 3-kinase and calcium-dependent PKC pathways [83].”
BackgroundTheogaraj, E., John, C. D., Christian, H., Morris, J. F., Smith, S. F., & Buckingham, J. C. (2005) · Endocrinology · doi:10.1210/en.2005-0500 · Cited by 49
“It is found in abundance in the anterior pituitary gland, in which it is localized to the nonendocrine S100-positive folliculostellate (FS) cells (23) and its expression (24), phosphorylation status (25, 26 ), and subcellular localization (27, 28) are regulated by GCs.”
BackgroundSelf-citationGlucocorticoid signaling and osteoarthritis
Savvidou, O. D., Milonaki, M., Goumenos, S. D., Flevas, D. A., Papagelopoulos, P. J., & Moutsatsou, P. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.11.001 · Cited by 50
John, C. D., Christian, H. C., Morris, J. F., Flower, R. J., Solito, E., & Buckingham, J. C. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.01081.x · Cited by 44
Self-citationYazid, S., Sinniah, A., Solito, E., Calder, V. L., & Flower, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058963 · Cited by 43
“This GC-induced secretory event is preceded by phosphorylation at Ser (and other sites), apparently as a result of PKC activation [41–43] by a glucocorticoid receptor (GR)-dependent mechanism.”
BackgroundSelf-citationNongenomic glucocorticoid effects and their mechanisms of action in vertebrates
Johnstone, W. M., Mankiewicz, J. L., Deck, C. A., & Borski, R. J. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.03.004 · Cited by 47
Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization
McArthur, S., Yazid, S., Christian, H., Sirha, R., Flower, R., Buckingham, J., & Solito, E. (2009) · The FASEB Journal · doi:10.1096/fj.09-131391 · Cited by 42
“Although we have previously shown that glucocorticoids affect ANXA1 phosphorylation and induce membrane translocation (16), the molecular and cellular mechanism of action”
BackgroundSelf-citationTargeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease
Costa, V. V., Sugimoto, M. A., Hubner, J., Bonilha, C. S., Queiroz‐Junior, C. M., Gonçalves-Pereira, M. H., Chen, J., Gobbetti, T., Rodrigues, G. O. L., Bambirra, J. L., et al. (2022) · eLife · doi:10.7554/elife.73853 · Cited by 42
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1
Yazid, S., Solito, E., Christian, H., McArthur, S., Goulding, N. J., & Flower, R. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.010 · Cited by 46
Self-citationLi, J., Liu, D., Wu, J., Zhang, D., Cheng, B., Zhang, Y., Yin, Z., Wang, Y., Du, J., & Ling, C. (2016) · Scientific Reports · doi:10.1038/srep39336 · Cited by 41
Cell Membrane–Associated Mineralocorticoid Receptors? New Evidence
Krug, A. W., Pojoga, L. H., Williams, G. H., & Adler, G. K. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.159459 · Cited by 42
Tierney, T., . Christian, H. C., . Morris, J. F., Solito, E., & . Buckingham, J. C. (2003) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2003.01111.x · Cited by 40
Self-citationDindia, L. A., Faught, E., Leonenko, Z., Thomas, R., & Vijayan, M. M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00500.2012 · Cited by 48
Yazid, S., Leoni, G., Getting, S. J., Cooper, D., Solito, E., Perretti, M., & Flower, R. J. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.209536 · Cited by 39
Self-citationEnteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 39
John, C., Sahni, V., Mehet, D. K., Morris, J. F., Christian, H., Perretti, M., Flower, R. J., Solito, E., & Buckingham, J. C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7299com · Cited by 36
“The cell surface form of the protein is serine-phosphorylated, a modification that appears essential both for the translocation of the protein across the membrane and for the biological activity of the protein (11, 12 ).”
BackgroundSelf-citationReynolds, S. D., Reynolds, P. R., Snyder, J. C., Whyte, F., Paavola, K. J., & Stripp, B. R. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00014.2007 · Cited by 36
“Since differential posttranslational modification of ANXA1 has been linked with changes in its subcellular localization (34), we sought to determine the cellular and subcellular distribution of ANXA1 expression within airways of wild-type and CCSP / mice.”
BackgroundVerrière, V., Hynes, D., Faherty, S., Devaney, J., Bousquet, J., Harvey, B. J., & Urbach, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506584200 · Cited by 35
Annexin A1 and the formyl peptide receptor family: neuroendocrine and metabolic aspects
John, C., Gavins, F. N. E., Buss, N. A. P. S., Cover, P. O., & Buckingham, J. C. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.09.005 · Cited by 44
Self-citationTranscriptional Regulation of Human Transforming Growth Factor-α in Astrocytes
Karki, P., Johnson, J., Son, D., Aschner, M., & Lee, E.-S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9705-9 · Cited by 35
“genomic pathways, which involve activation of intracellular signaling proteins after activation of the GR by GCs including DX, have also been reported to regulate several genes [66].”
The Anti-allergic Cromones: Past, Present, and Future
Sinniah, A., Yazid, S., & Flower, R. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00827 · Cited by 34
“Previous experimental observations had revealed that GC receptor ligation, perhaps acting through phosphatidylinositol 3-kinase (Solito et al., 2003), causes PKC activation and membrane translocation and that this activity was limited by dephosphorylation, through the Ser/Thr PP2A phosphatase…”
Self-citationGlucocorticoid‐stimulated, transcription‐independent release of annexin A1 by cochlear Hensen cells
Kalinec, F., Webster, P. C., Maricle, A., Guerrero, D., Chakravarti, D., Chakravarti, B., Gellibolian, R., & Kalinec, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00473.x · Cited by 32
“…hydrophobic signal sequence in its amino terminus, in some cell types externalization of ANXA1 is stimulated by glucocorticoid treatment in a time- and concentration-dependent manner (Solito et al., 2003) that does not involves the classical secretory pathway (Wein et al., 2004; Omer et al., 2006).”
BackgroundGros, R., Ding, Q., Davis, M., Shaikh, R., Liu, B., Chorazyczewski, J., Pickering, J. G., & Feldman, R. D. (2011) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-062 · Cited by 33
Kwon, J. H., Lee, J. H., Kim, K. S., Chung, Y. W., & Kim, I. Y. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102306 · Cited by 32
“The N-terminal peptide is known to be cleaved by a number of proteases, including elastase, calpain, plasmin, cathepsin D, and proteinase 3 (11–14), and is also phosphorylated to regulate the activity of the protein (15, 16).”
BackgroundPangault, C., Tulzo, Y. L., Tattevin, P., Guilloux, V., Bescher, N., & Drénou, B. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000207339.11477.62 · Cited by 31
“Interestingly, several stress hormones released in high concentrations during septic shock, such as catecholamines and cortisol, can increase protein kinase C activity (22, 23) and therefore may be involved via this mechanism in GM-CSFr down-modulation.”
BackgroundÁlvarez–Teijeiro, S., Menéndez, S. T., Villaronga, M. Á., Alonso, E. P., Rodrigo, J. P., Morgan, R. O., Granda‐Díaz, R., Lucena, C. S., Fernández, M. P., & Garcia-Pedrero, J. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-07169-w · Cited by 32
The Tolerogenic Function of Annexins on Apoptotic Cells Is Mediated by the Annexin Core Domain
Linke, B., Abeler‐Dörner, L., Jahndel, V., Kurz, A., Mahr, A., Pfrang, S., Linke, L., Krammer, P. H., & Weyd, H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401299 · Cited by 30
Pei, T., Su, G., Yang, J., Gao, W., Yang, X., Zhang, Y., Ren, J., Shen, Y., & Liu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415702 · Cited by 31
“In general, AnxA is homogeneously distributed in the cytoplasm while responding to certain stimuli, such as glucocorticoids [35,36], inflammation [36], a high concentration of calcium [37], or FSS [14].”
Ling-lin, W., Ou, C.-C., & Chan, J. Y. H. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005595 · Cited by 26
“At the signal transduction level, activation of phosphatidylinositol 3-kinase (PI3K) (Solito et al., 2003) and serine/threonine kinase Akt (Akt) (Buren et al.”
BackgroundKaljusto, M., Stensløkken, K., Mori, T., Панченко, А. В., Frantzen, M.-L., Valen, G., & Vaage, J. (2008) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.12.017 · Cited by 26
“Recent findings suggest the presence of rapid, nontranscriptional effects of steroids both in the heart and vasculature, possibly via activation of phosphatidylinositol 3-kinase and AKT [10].”
BackgroundSafy‐Khan, M., de Hair, M. J. H., Jacobs, J. W. G., Buttgereit, F., Kraan, M. C., & van Laar, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188810 · Cited by 31
Seale, A. P., Yamaguchi, Y., Johnstone, W. M., Borski, R. J., Lerner, D. T., & Grau, E. G. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.05.011 · Cited by 32
Effect of annexin-A1 peptide treatment during lung inflammation induced by lipopolysaccharide
da Cunha, E. E., Oliani, S. M., & Damazo, A. S. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.04.002 · Cited by 26
Ayrout, M., Simon, V., Bernard, V., Binart, N., Cohen-Tannoudji, J., Lombès, M., & Chauvin, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-01777-2 · Cited by 36
Folliculo-stellate Cells: Paracrine Communicators in the Anterior Pituitary
Morris, J. F. (2011) · The Open Neuroendocrinology Journal · doi:10.2174/1876528901104010077 · Cited by 27
“The PDFS cells also export Anx A1 [32] and express toll-like receptor (Tlr4), the receptor which induces lipopolysaccharide signals [33].”
BackgroundSelf-citation
Metadata
- Authors
- Solito, E., Mulla, A., Morris, J. F., Christian, H. C., Flower, R. J., & Buckingham, J. C.
- Affiliations
- Hammersmith Hospital (GB)
- University of Oxford (GB)
- William Harvey Research Institute (GB)
- Corresponding author
- Solito, Egle
- Buckingham, Julia C.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-04-01
- Volume
- 144
- Issue
- 4
- Pages
- 1164-1174
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2069585979
- Cited by
- 184
- References
- 67
- Citations by year
- 2026: 5 · 2024: 5 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 8 · 2018: 7 · 2017: 10 · 2016: 7 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 12
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › S100 Proteins and Annexins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- annexin A1, dexamethasone, glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, mitogen-activated protein kinase, serine phosphorylation, membrane translocation, folliculostellate cells, ACTH secretion, mifepristone, annexin V
- MeSH terms
- Phosphoinositide-3 Kinase Inhibitors, Animals, Cell Membrane, Dexamethasone, Enzyme Inhibitors, Glucocorticoids, Humans, Phosphorylation, Pituitary Neoplasms, Protein Kinase C, Rabbits, Receptors, Glucocorticoid, Serine, Tumor Cells, Cultured, Gene Expression, Annexin A1, Adenocarcinoma, Follicular, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.